Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-13

FDA Approved: VALCHLOR — Supplemental Application (Helsinn Therapeutics (U.S.), Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VALCHLOR (mechlorethamine hydrochloride) from Helsinn Therapeutics (U.S.), Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valchlor (mechlorethamine)

Snippet

SUPPL AP for VALCHLOR (MECHLORETHAMINE HYDROCHLORIDE)